Skip to content

A prospective cohort study of Yangyin moisturizing ointment to intervene in patients with psoriasis vulgaris recurrence

A prospective cohort study of Yangyin moisturizing ointment to intervene in patients with psoriasis vulgaris recurrence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000159
Enrollment
Unknown
Registered
2024-08-01
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

Healthy subject group:No intervention
Oral Chinese medicine ointment formula group:Take the cream daily in the morning and evening for 12 weeks
Observation group:No intervention was done during this period, only follow-up.

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with psoriasis (1) Meet the diagnostic criteria for plaque psoriasis vulgaris; (2) 18 years old< age = 70 years old; (3) Standardized injection of secukinumab injection for more than 12 weeks, 4~8 weeks after the last injection, and the willingness to stop the drug; (4) PGA score =1, BSA =3%; (5) Signed informed consent and willing to accept follow-up. Inclusion Criteria for Healthy Subjects. Healthy control group: healthy subjects who will visit the China Academy of Chinese Medical Sciences from January 1, 2024 to November 1, 2026 The inclusion criteria are as follows: (1) 18 years old< age = 70 years old; (2) Persons with a physical examination (without a clear diagnosis of disease); (3) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with psoriasis (1) Pregnant, planning pregnancy and lactating women; (2) Systemic glucocorticoids, immunosuppressants, and retinoids within 4 weeks; (3) Patients with severe liver and kidney insufficiency; (4) Patients with severe mental illness; (5) Participated in other clinical trials in the past three months. Exclusion criteria for healthy subjects (1) Pregnant, planning pregnancy and lactating women; (2) Participated in other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
Whether psoriasis recurred within 48 weeks of enrollment.;

Secondary

MeasureTime frame
Physical trait analysis;Genome-wide DNA methylation sequencing of peripheral blood mononuclear cells;Physician Global Assessment Score;BSA;

Countries

China

Contacts

Public ContactCui Bingnan

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

cbn1998@163.com+86 133 0405 1090

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026